Failure modes and effects analysis of pediatric I-131 MIBG therapy: Program design and potential pitfalls.

Nichole M MaughanJose L Garcia-RamirezFrederick S HuangDaniel N WillisAmir IravaniMaxwell AmuraoDavid LuechtefeldJoyce C MhlangaStephanie M PerkinsJacqueline E Zoberi

Published in: Pediatric blood & cancer (2022)

Through use of FMEA methodology, we successfully identified multiple potential points of failure that have allowed us to proactively mitigate risks when implementing a pediatric MIBG program.

Keyphrases

quality improvement
human health
stem cells
climate change
bone marrow